Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3557 | WHWK Whitehawk Therapeutics, Inc. - Common Stock | 3.47 USD | +1.76% | -8.92% | -15.98% | +15.28% | 197.82 M USD | ||
| 3558 | ACOG Alpha Cognition Inc. - Common Stock | 9.04 USD | 0.00% | +3.91% | +1.23% | +18.48% | 196.87 M USD | ||
| 3560 | ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 2.42 USD | 0.00% | -2.42% | -12.95% | -18.79% | 196.65 M USD | ||
| 3563 | SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 70.34 USD | -2.24% | -3.49% | +1.35% | +75.94% | 195.98 M USD | ||
| 3573 | BCYC Bicycle Therapeutics plc - American Depositary Shares | 3.81 USD | +2.14% | +4.38% | -4.51% | -57.53% | 192.61 M USD | ||
| 3606 | ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 2.51 USD | -1.57% | -4.92% | -32.89% | +36.41% | 179.90 M USD | ||
| 3611 | DTIL Precision BioSciences, Inc. - Common Stock | 6.43 USD | +2.88% | +0.16% | -10.20% | +9.35% | 177.48 M USD | ||
| 3615 | ANTX AN2 Therapeutics, Inc. - Common Stock | 4.68 USD | -3.51% | -17.02% | -15.83% | +274.40% | 176.61 M USD | ||
| 3617 | CMPX Compass Therapeutics, Inc. - Common Stock | 0.98 USD | -3.92% | +4.26% | -54.42% | -75.92% | 176.49 M USD | ||
| 3623 | ORMP Oramed Pharmaceuticals Inc. - Common Stock | 4.20 USD | -3.89% | -7.28% | -11.39% | +76.47% | 174.71 M USD | ||
| 3638 | PYXS Pyxis Oncology, Inc. - Common Stock | 1.99 USD | -1.00% | -9.95% | -41.81% | -48.04% | 165.98 M USD | ||
| 3641 | PRQR ProQR Therapeutics N.V. - Ordinary Shares | 1.57 USD | -3.68% | -4.85% | -19.90% | -37.45% | 165.42 M USD | ||
| 3642 | CHRS Coherus Oncology, Inc. - Common Stock | 1.07 USD | +5.94% | -10.08% | -19.55% | -33.54% | 165.32 M USD | ||
| 3643 | PEPG PepGen Inc. - Common Stock | 2.38 USD | -0.83% | +6.25% | -23.96% | -51.43% | 164.84 M USD | ||
| 3648 | ALXO ALX Oncology Holdings Inc. - Common Stock | 1.18 USD | +4.42% | -10.61% | -36.22% | -39.18% | 163.17 M USD | ||
| 3652 | CUE Cue Biopharma, Inc. - Common Stock | 22.33 USD | -0.80% | -12.77% | -26.06% | +2301.08% | 162.21 M USD | ||
| 3664 | MDWD MediWound Ltd. - Ordinary Shares | 12.42 USD | -3.35% | -8.81% | -9.61% | -33.01% | 159.41 M USD | ||
| 3666 | NKTX Nkarta, Inc. - Common Stock | 2.22 USD | -2.20% | -14.62% | -22.92% | -5.93% | 159.01 M USD | ||
| 3668 | NBP NovaBridge Biosciences - American Depositary Shares | 1.37 USD | 0.00% | +2.24% | -17.96% | -69.62% | 158.07 M USD | ||
| 3673 | TARA Protara Therapeutics, Inc. - Common Stock | 2.65 USD | +2.32% | -5.69% | -30.26% | -53.51% | 156.60 M USD |
Notícias Biotechnology Stocks
Estudo da Lancet mostra alívio mais rápido com remédio da Pharvaris para AEH
Raymond James inicia cobertura da Kymera Therapeutics com recomendação acima da média
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |